Kamada Ltd. (TLV:KMDA)
2,261.00
+1.00 (0.04%)
Jan 1, 2026, 5:24 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.3 billion as of December 31, 2025. Its market cap has increased by 2.32% in one year.
Market Cap
1.30B
Enterprise Value
1.10B
Revenue
578.74M
Ranking
n/a
PE Ratio
19.54
Stock Price
2,261.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.30B, an increase of 1,446.82%. That is a compound annual growth rate of 14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 114.39B |
| Danel (Adir Yeoshua) | 2.89B |
| BrainsWay | 1.19B |
| SofWave Medical | 1.01B |
| Bait Bakfar | 991.66M |
| Ilex Medical | 745.80M |
| Novolog (Pharm-Up 1966) | 655.96M |
| Bonus BioGroup | 293.15M |